These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30650201)

  • 1. Exploring the potential for rosacea therapeutics of siRNA dispersion in topical emulsions.
    Colombo S; Harmankaya N; Water JJ; Bohr A
    Exp Dermatol; 2019 Mar; 28(3):261-269. PubMed ID: 30650201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.
    Zhang J; Jiang P; Sheng L; Liu Y; Liu Y; Li M; Tao M; Hu L; Wang X; Yang Y; Xu Y; Liu W
    Front Immunol; 2021; 12():609615. PubMed ID: 34322115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro/in vivo characterization of nanoemulsion formulation of metronidazole with improved skin targeting and anti-rosacea properties.
    Yu M; Ma H; Lei M; Li N; Tan F
    Eur J Pharm Biopharm; 2014 Sep; 88(1):92-103. PubMed ID: 24704200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL1 gene silencing in skin using liposome-encapsulated siRNA delivered by microprojection array.
    Haigh O; Depelsenaire AC; Meliga SC; Yukiko SR; McMillan NA; Frazer IH; Kendall MA
    J Control Release; 2014 Nov; 194():148-56. PubMed ID: 25192942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical delivery of siRNA into skin using SPACE-peptide carriers.
    Chen M; Zakrewsky M; Gupta V; Anselmo AC; Slee DH; Muraski JA; Mitragotri S
    J Control Release; 2014 Apr; 179():33-41. PubMed ID: 24434423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo gene silencing following non-invasive siRNA delivery into the skin using a novel topical formulation.
    Hegde V; Hickerson RP; Nainamalai S; Campbell PA; Smith FJ; McLean WH; Pedrioli DM
    J Control Release; 2014 Dec; 196():355-62. PubMed ID: 25449884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells.
    Ritprajak P; Hashiguchi M; Azuma M
    Mol Ther; 2008 Jul; 16(7):1323-30. PubMed ID: 18461054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea.
    Yuan X; Li J; Li Y; Deng Z; Zhou L; Long J; Tang Y; Zuo Z; Zhang Y; Xie H
    Biomed Pharmacother; 2019 Sep; 117():109181. PubMed ID: 31387196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea.
    Shinde UA; Parmar SJ; Easwaran S
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1039-1051. PubMed ID: 30727789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of PD-L2/B7-DC by Topical Application of Small Interfering RNA Inhibits Elicitation of Contact Hypersensitivity.
    Furusawa E; Ohno T; Nagai S; Noda T; Komiyama T; Kobayashi K; Hamamoto H; Miyashin M; Yokozeki H; Azuma M
    J Invest Dermatol; 2019 Oct; 139(10):2164-2173.e1. PubMed ID: 30978356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-RelA siRNA-Encapsulated Flexible Liposome with Tight Junction-Opening Peptide as a Non-invasive Topical Therapeutic for Atopic Dermatitis.
    Ibaraki H; Kanazawa T; Kurano T; Oogi C; Takashima Y; Seta Y
    Biol Pharm Bull; 2019; 42(7):1216-1225. PubMed ID: 31257297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical delivery of siRNA into skin using ionic liquids.
    Dharamdasani V; Mandal A; Qi QM; Suzuki I; Bentley MVLB; Mitragotri S
    J Control Release; 2020 Jul; 323():475-482. PubMed ID: 32339547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase.
    Depieri LV; Borgheti-Cardoso LN; Campos PM; Otaguiri KK; Vicentini FT; Lopes LB; Fonseca MJ; Bentley MV
    Eur J Pharm Biopharm; 2016 Aug; 105():50-8. PubMed ID: 27224855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pickering emulsions: challenges and opportunities in topical delivery.
    Marto J; Ascenso A; Simoes S; Almeida AJ; Ribeiro HM
    Expert Opin Drug Deliv; 2016 Aug; 13(8):1093-107. PubMed ID: 27108850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical rosacea therapy: the importance of vehicles for efficacy, tolerability and compliance.
    Jackson JM; Pelle M
    J Drugs Dermatol; 2011 Jun; 10(6):627-33. PubMed ID: 21637903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current topical and systemic approaches to treatment of rosacea.
    Korting HC; Schöllmann C
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):876-82. PubMed ID: 19508315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo application of RNA interference: from functional genomics to therapeutics.
    Lu PY; Xie F; Woodle MC
    Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse.
    Takanashi M; Oikawa K; Sudo K; Tanaka M; Fujita K; Ishikawa A; Nakae S; Kaspar RL; Matsuzaki M; Kudo M; Kuroda M
    Gene Ther; 2009 Aug; 16(8):982-9. PubMed ID: 19474812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical application of siRNA targeting cutaneous dendritic cells in allergic skin disease.
    Azuma M; Ritprajak P; Hashiguchi M
    Methods Mol Biol; 2010; 623():373-81. PubMed ID: 20217564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in Topical siRNA Delivery Approaches for Skin Disorders.
    Aldawsari M; Chougule MB; Babu RJ
    Curr Pharm Des; 2015; 21(31):4594-605. PubMed ID: 26362644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.